drugset / Trial / NCT00325299

Magnesium After Alcohol Withdrawal Treatment

NCT00325299

Phase 4 Completed 178 enrolled Finnish Foundation for Alcohol Studies
RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose is to see if magnesium tablet supplementation will decrease elevated GGT enzyme activity in alcoholic patients immediately after they had been treated for alcohol withdrawal. The secondary aims are to find out whether supplementation decreases the activity of ASAT and ALAT enzymes, increases muscle strength, decreases blood pressure and decreases depressive symptoms among these patients.

Timeline

Start
Primary completion
Completion
2005-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 500 mg Oral